Mechanisms of Increased Disease Severity in AD Patients With the IL-4Ra R576 Polymorphism

Part of paid clinical trials in Boston, Massachusetts.

Sponsor
Boston Children's Hospital
Study ID
NCT04455906
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
6 Years - 65 Years
Healthy Volunteers
Not accepted

Study Details

This protocol is primarily looking to see if the IL-4Ra R576 polymorphism is associated with increased clinical, immunological and microbial markers of disease activity in patients with Atopic dermatitis.

Key Dates

Start date
Nov 30, 2020
Status verified
May 2026
Primary completion
Mar 15, 2027
Completion
Sep 15, 2027

Study Design

Enrollment
111 participants (estimated)

Primary Outcome Measure

atopic dermatitis severity [ Time Frame: baseline, only 1 time point ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Boston Children's HospitalBostonMassachusetts02115
Amparito Cunningham
[email protected]
857-218-5336

Find similar trials in Boston, MA

By condition
Atopic dermatitis / eczema
By specialty
DermatologyRheumatologyAutoimmune disease
By research site
Boston Children's Hospital· Boston, MA

Related Studies